Table 3. Examples of Electrochemical Biosensor Devices Developed to Early Detect Cancer Cells.
| sensor | sample | analyte | electrochemical method | limit of detection | linear range | reference |
|---|---|---|---|---|---|---|
| dhDNA (Fc-AP-21/MB-HCP) onto GCE | human plasma | miRNA-141 | SWV | 0.89 fM | 2.0 to 105 fM | (201) |
| miRNA-21 | 1.24 fM | |||||
| GO–CS/PVP-AuNUs onto GCE | human plasma | miRNA-141 | SWV | 0.94 fM | 2.0 to 5.0 × 105 fM | (202) |
| AuNPs/Ni-catecholates/carbon black/polarized pencil graphite electrode (AuNPs/Ni-CAT/CB/PPGE) | serum samples like liquid biopsy | ctDNA from EGFR 19 Dels for NSCLC | DPV | 0.32 fM | 1.10–15 to 1.10–6 M | (203) |
| PER-CRISPR/Cas14a | synthetic samples | ctDNA EGFR L858R | DPV | 0.34 fM | 1 fM to 1 μM | (204) |
| alDNA sensor | human serum sample | KRAS point mutation level from M-DNA | SWV | 100 pM to 10 nM | (187) | |
| g-G-AuNP-dsDNA | synthetic sample | anti-p53 antibody | CV and EIS | 0.6 fM | 0.1 ng/L to 0.1 μg/L | (185) |
| SnO2-QD-Au modified with DNA onto AuE | synthetic sample | anti-p53 antibody | EIS | 3.2 aM | 1.10–6 to 1.10–20 M | (205) |